These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20044606)

  • 1. Infrequent amplification of JUN in hepatocellular carcinoma.
    Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
    Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma.
    Inagaki Y; Yasui K; Endo M; Nakajima T; Zen K; Tsuji K; Minami M; Tanaka S; Taniwaki M; Itoh Y; Arii S; Okanoue T
    Cancer Genet Cytogenet; 2008 Jan; 180(1):30-6. PubMed ID: 18068530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array.
    Park SJ; Jeong SY; Kim HJ
    Cancer Genet Cytogenet; 2006 Apr; 166(1):56-64. PubMed ID: 16616112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma.
    Tsuji K; Yasui K; Gen Y; Endo M; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Apr; 198(2):118-25. PubMed ID: 20362226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
    Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
    Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of the regions of copy number amplification associated with hepatocellular carcinoma].
    Zhang SG; Gao YT; Song WQ; Du Z; Yang B; Wang YJ; Zhu ZY
    Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):566-70. PubMed ID: 20021941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
    Wang Y; Wu MC; Sham JS; Zhang W; Wu WQ; Guan XY
    Cancer; 2002 Dec; 95(11):2346-52. PubMed ID: 12436441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
    Chan KL; Guan XY; Ng IO
    Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual fluorescence in situ hybridization in detection of HER-2 oncogene amplification in primary hepatocellular carcinoma.
    Huang TJ; Huang BJ; Liang QW; Huang CW; Fang Y
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):62-8. PubMed ID: 14969840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas.
    Yasui K; Arii S; Zhao C; Imoto I; Ueda M; Nagai H; Emi M; Inazawa J
    Hepatology; 2002 Jun; 35(6):1476-84. PubMed ID: 12029633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.
    Olejniczak ET; Van Sant C; Anderson MG; Wang G; Tahir SK; Sauter G; Lesniewski R; Semizarov D
    Mol Cancer Res; 2007 Apr; 5(4):331-9. PubMed ID: 17426248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.
    Buckley AF; Burgart LJ; Kakar S
    Hum Pathol; 2006 Apr; 37(4):410-4. PubMed ID: 16564914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization of hepatocellular carcinoma: correlation with fluorescence in situ hybridization in paraffin-embedded tissue.
    Rao UN; Gollin SM; Beaves S; Cieply K; Nalesnik M; Michalopoulos GK
    Mol Diagn; 2001 Mar; 6(1):27-37. PubMed ID: 11257209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry.
    Zen K; Yasui K; Nakajima T; Zen Y; Zen K; Gen Y; Mitsuyoshi H; Minami M; Mitsufuji S; Tanaka S; Itoh Y; Nakanuma Y; Taniwaki M; Arii S; Okanoue T; Yoshikawa T
    Genes Chromosomes Cancer; 2009 Feb; 48(2):109-20. PubMed ID: 18973138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas.
    Okamoto H; Yasui K; Zhao C; Arii S; Inazawa J
    Hepatology; 2003 Nov; 38(5):1242-9. PubMed ID: 14578863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays.
    Midorikawa Y; Yamamoto S; Ishikawa S; Kamimura N; Igarashi H; Sugimura H; Makuuchi M; Aburatani H
    Oncogene; 2006 Sep; 25(40):5581-90. PubMed ID: 16785998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amplification of RIT1 in hepatocellular carcinoma and its clinical significance].
    Li JT; Liu W; Kuang ZH; Chen HK; Li DJ; Feng QS; Liu QC; Hu B
    Ai Zheng; 2003 Jul; 22(7):695-9. PubMed ID: 12866958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.